Sutton Wealth Advisors Inc. Glaukos Corp Transaction History

Sutton Wealth Advisors Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$43.88 - $52.48 $63,274 - $75,676	-1,442 Closed	0 $0
Q3 2022 Nov 07, 2023	SELL	$46.84 - $58.49 $3,606 - $4,503	-77 Reduced 5.07%	1,442 $76.8 Million
Q2 2022 Nov 07, 2023	BUY	$34.86 - $63.77 $17,151 - $31,374	492 Added 47.91%	1,519 $69 Million
Q4 2021 Nov 07, 2023	BUY	$40.27 - $56.99 $442 - $626	11 Added 1.08%	1,027 $45.6 Million
Q3 2020 Nov 07, 2023	SELL	$37.23 - $50.97 $9,419 - $12,895	-253 Reduced 19.94%	1,016 $50.3 Million
Q2 2020 Nov 07, 2023	BUY	$28.78 - $46.83 $36,521 - $59,427	1,269 New	1,269 $48.8 Million

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.